Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -17,040 | -11,204 | -6,805 |
| Depreciation Amortization | 79 | 47 | 31 |
| Accounts receivable | N/A | -368 | -90 |
| Accounts payable and accrued liabilities | N/A | 912 | 602 |
| Other Working Capital | 1,253 | 1,119 | 532 |
| Other Operating Activity | 1,087 | 327 | 48 |
| Operating Cash Flow | $-14,621 | $-9,168 | $-5,682 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -53 | -15 | -10 |
| Investing Cash Flow | $-53 | $-15 | $-10 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 37,982 | 998 | 998 |
| Financing Cash Flow | $37,982 | $998 | $998 |
| Beginning Cash Position | 13,782 | 13,782 | 13,782 |
| End Cash Position | 37,090 | 5,597 | 9,089 |
| Net Cash Flow | $23,308 | $-8,185 | $-4,693 |
| Free Cash Flow | |||
| Operating Cash Flow | -14,621 | -9,168 | -5,682 |
| Capital Expenditure | N/A | -15 | -10 |
| Free Cash Flow | -14,621 | -9,183 | -5,692 |